script.reportAU
Register
← The record

Ocular Lubricants (Multiple Active Ingredients)

Noted OphthalmologyRestrictedNot applicable line

Dry eye syndrome and related conditions requiring ocular lubrication. The assessment considered pricing equivalence across preservative-containing and preservative-free formulations.

1
Submissions
1 resub
2014–14
On the record
—
ICER range
Cost-min
Cost basis

Decisions on record

2 decisions
  • Meeting Jul 2024 Noted Severe dry eye syndrome no PSD
  • Meeting Nov 2014 Recommended Various products Various sponsors (Review) Ocular lubricants To consider the findings of the DUSC utilisation analysis of ocular lubricants and consider if the current pricing of ocular lubricants is appropriate.

Access path

1 submission · public record
  1. Nov 2014
    Recommended · restricted

    vs cost-minimisation basis across equivalent ocular lubricant…

  2. PBS listing · Restricted
RecommendedDeferredNot recommended

From the public summary

Verbatim · PSD text · may span indications
PBAC outcome
3.1 The PBAC recommended that all ocular lubricants should be considered equivalent for pricing purposes. The PBAC noted that this recommendation includes ocular lubricants that contain a preservative, those that are preservative free, multi-dose products and single dose unit products.PSD · Nov 2014
3.2 The PBAC considered that no evidence was presented to conclude any difference in patient outcomes between the various ocular lubricants.PSD · Nov 2014

Cost-effectiveness

Cost-minimisation analysis; no ICER calculated by design.

The PBAC considered that no evidence was presented to conclude any difference in patient outcomes between the various ocular lubricants. PBAC · 2014
Economic model disputedNo head-to-head trial

Decision context

PopulationPatients with dry eye syndrome, including those sensitive to preservatives in multi-dose eye drops; severe dry eye syndrome for certain single-dose carmellose formulations.

Submission history

1 entries
DecidedOutcomeComparatorICEREvidence
Nov 2014 Recommended · restricted cost-minimisation basis across equivalent ocular lubricant formulations — Cost-minimisation · Cost-minimisation

Similar precedents

By decision profile
Carmellose Sodium; Hypromellose81%Hyaluronic Acid With Polyethylene Glycol 400 With Propylene Glycol With Hydroxypropyl Guar77%Cationic Ophthalmic Emulsion, Preservative Free76%Polyethylene Glycol 400 With Propylene Glycol75%Propylene Glycol73%Perfluorohexyloctane72%Tsp (Tamarindus Indica Seed Polysaccharide)72%Carmellose Sodium With Glycerol And Hyaluronic Acid70%